MaaT Pharma is Participating to the Microbiome Drug Development Summit in Boston from 28 to 30 June 2016 Read more ——————— MaaT Pharma announces the creation of its Scientific Advisory Board (SAB). MaaT Pharma, a leader in the intestinal microbiome industry and pioneer in Autologous Faecal Microbiotherapy, today announced the creation of its international Scientific Advisory Board of acknowledged experts in the fields of intestinal microbiome, haematology, gastroenterology, bacteriology and clinical trial methodology Read more ——————— MaaT Pharma will be participating to the BIO Convention in San Francisco this year from 6 to 9 june 2016. Come and see us at Booth #705.
- MaaT Pharma completes patient recruitment of its Odyssée clinical trial
- MaaT Pharma announces CE marking for its globally unique medical device
- A major step in the restoration of Gut Microbiota: MaaT Pharma and Biocodex to industrialize FMT & develop an oral formulation
- LA DYSBIOSE
- QUAND LES SELLES PEUVENT NOUS SOIGNER !